Stocks News

LAST PRICE
133.0200
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
133.0400/ 2
Ask / Lots
134.2000/ 10
Open / Previous Close
135.2100 / 133.0200
Day Range
Low 133.0100
High 139.9600
52 Week Range
Low 36.4201
High 144.2250
Volume
501,524
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Jun 5, 2024
- Transmedics Group Insider Sold Shares Worth $393,986, According to a Recent SEC Filing, from 5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires
  5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires
  Companies Mentioned: TMDX
  05:18 PM EDT, 06/05/2024 (MT Newswires) -- Tamer I Khayal, Chief Commercial Officer, on June 03, 2024, sold 2,960 shares in Transmedics Group (TMDX) for $393,986. Following the Form 4 filing with the SEC, Khayal has control over a total of 20,843 sh...
- Transmedics Group Insider Sold Shares Worth $280,016, According to a Recent SEC Filing, from 5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires
  5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires
  Companies Mentioned: TMDX
  05:18 PM EDT, 06/05/2024 (MT Newswires) -- Stephen Gordon, Chief Financial Officer, on June 03, 2024, sold 2,060 shares in Transmedics Group (TMDX) for $280,016. Following the Form 4 filing with the SEC, Gordon has control over a total of 21,299 sha...
Jun 4, 2024
- --Stephens Initiates TransMedics at Overweight Rating With $151 Price Target, from 8:21AM ET on Tuesday Jun 04, 2024 by MT Newswires
  8:21AM ET on Tuesday Jun 04, 2024 by MT Newswires
  Companies Mentioned: TMDX
  08:21 AM EDT, 06/04/2024 (MT Newswires) -- Price: 134.93, Change: +1.30, Percent Change: +0.97 ...
- Stephens Starts TransMedics Group With Overweight Rating, $151 Price Target, from 6:08AM ET on Tuesday Jun 04, 2024 by MT Newswires
  6:08AM ET on Tuesday Jun 04, 2024 by MT Newswires
  Companies Mentioned: TMDX
  06:08 AM EDT, 06/04/2024 (MT Newswires) -- TransMedics Group (TMDX) has an average rating of outperform and price targets ranging from $104 to $130, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic rese...
- DJ TransMedics Group Initiated at Overweight by Stephens & Co., from 6:08AM ET on Tuesday Jun 04, 2024 by Dow Jones
  6:08AM ET on Tuesday Jun 04, 2024 by Dow Jones
  Companies Mentioned: TMDX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 04, 2024 06:08 ET (10:08 GMT)

Yesterday
- Cytek Biosciences Board Approves $50 Million Share Buyback Plan, from 18 hours ago by MT Newswires
  18 hours ago by MT Newswires
  Companies Mentioned: CTKB
- Cytek Biosciences Announces $50 Million Stock Repurchase Program, from 19 hours ago by GlobeNewswire
  19 hours ago by GlobeNewswire
  Companies Mentioned: CTKB
Jun 4, 2024
- iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference, from 4:05PM ET on Tuesday Jun 04, 2024 by GlobeNewswire
  4:05PM ET on Tuesday Jun 04, 2024 by GlobeNewswire
  Companies Mentioned: IRTC
Jun 3, 2024
- Jefferies & Co Initiates Coverage on Pacific Biosciences of California With Buy Rating, $4 Price Target, from 7:39AM ET on Monday Jun 03, 2024 by MT Newswires
  7:39AM ET on Monday Jun 03, 2024 by MT Newswires
  Companies Mentioned: PACB
May 31, 2024
- Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), from 11:01PM ET on Friday May 31, 2024 by Accesswire
  11:01PM ET on Friday May 31, 2024 by Accesswire
  Companies Mentioned: SAVA, IRTC, XPOF, AMLX
- --Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target, from 7:37AM ET on Friday May 31, 2024 by MT Newswires
  7:37AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: LMAT
May 30, 2024
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:05PM ET on Thursday May 30, 2024 by GlobeNewswire
  4:05PM ET on Thursday May 30, 2024 by GlobeNewswire
  Companies Mentioned: CTKB
May 29, 2024
- Lifshitz Law PLLC Announces Investigations of bluebird bio, Inc. (NASDAQ:BLUE), Fox Factory Holding Corp. (NASDAQ:FOXF), The Lovesac Company (NASDAQ:LOVE), and iRhythm Technologies, Inc. (NASDAQ:IRTC), from 11:49PM ET on Wednesday May 29, 2024 by Accesswire
  11:49PM ET on Wednesday May 29, 2024 by Accesswire
  Companies Mentioned: IRTC, LOVE, BLUE, FOXF
- Sector Update: Health Care Stocks Lean Lower Premarket Wednesday, from 9:16AM ET on Wednesday May 29, 2024 by MT Newswires
  9:16AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: IBB, JAZZ, SRDX, XLV, CTKB
May 28, 2024
- Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China, from 6:01PM ET on Tuesday May 28, 2024 by MT Newswires
  6:01PM ET on Tuesday May 28, 2024 by MT Newswires
  Companies Mentioned: CTKB

Transmedics Group Inc
NASDAQ:TMDXUnited States

Search Criteria

Jun 5, 2024

Transmedics Group Insider Sold Shares Worth $393,986, According to a Recent SEC Filing, from 5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires

Transmedics Group Insider Sold Shares Worth $280,016, According to a Recent SEC Filing, from 5:18PM ET on Wednesday Jun 05, 2024 by MT Newswires

Jun 4, 2024

--Stephens Initiates TransMedics at Overweight Rating With $151 Price Target, from 8:21AM ET on Tuesday Jun 04, 2024 by MT Newswires

Stephens Starts TransMedics Group With Overweight Rating, $151 Price Target, from 6:08AM ET on Tuesday Jun 04, 2024 by MT Newswires

DJ TransMedics Group Initiated at Overweight by Stephens & Co., from 6:08AM ET on Tuesday Jun 04, 2024 by Dow Jones

Peers Headlines

Yesterday

Cytek Biosciences Board Approves $50 Million Share Buyback Plan, from 18 hours ago by MT Newswires

Cytek Biosciences Announces $50 Million Stock Repurchase Program, from 19 hours ago by GlobeNewswire

Jun 4, 2024

iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference, from 4:05PM ET on Tuesday Jun 04, 2024 by GlobeNewswire

Jun 3, 2024

Jefferies & Co Initiates Coverage on Pacific Biosciences of California With Buy Rating, $4 Price Target, from 7:39AM ET on Monday Jun 03, 2024 by MT Newswires

May 31, 2024

Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), from 11:01PM ET on Friday May 31, 2024 by Accesswire

--Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target, from 7:37AM ET on Friday May 31, 2024 by MT Newswires

May 30, 2024

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:05PM ET on Thursday May 30, 2024 by GlobeNewswire

May 29, 2024

Lifshitz Law PLLC Announces Investigations of bluebird bio, Inc. (NASDAQ:BLUE), Fox Factory Holding Corp. (NASDAQ:FOXF), The Lovesac Company (NASDAQ:LOVE), and iRhythm Technologies, Inc. (NASDAQ:IRTC), from 11:49PM ET on Wednesday May 29, 2024 by Accesswire

Sector Update: Health Care Stocks Lean Lower Premarket Wednesday, from 9:16AM ET on Wednesday May 29, 2024 by MT Newswires

May 28, 2024

Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China, from 6:01PM ET on Tuesday May 28, 2024 by MT Newswires